22q11.2 deletion syndrome.
McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, Zackai EH, Emanuel BS, Vermeesch JR, Morrow BE, Scambler PJ, Bassett AS.
Nat Rev Dis Primers. 2015 Nov 19;1:15071. doi: 10.1038/nrdp.2015.71.
22q11.2 deletion syndrome and congenital heart disease.
Goldmuntz E.
Am J Med Genet C Semin Med Genet. 2020 Mar;184(1):64-72. doi: 10.1002/ajmg.c.31774. Epub 2020 Feb 12.
Congenital hypoparathyroidism.
Laron Z.
Isr J Med Sci. 1995 May;31(5):326-7.
22q11.2 duplications: Expanding the clinical presentation.
Bartik LE, Hughes SS, Tracy M, Feldt MM, Zhang L, Arganbright J, Kaye A.
Am J Med Genet A. 2022 Mar;188(3):779-787. doi: 10.1002/ajmg.a.62577. Epub 2021 Nov 29.
Hypoparathyroidism.
Al-Azem H, Khan AA.
Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):517-22. doi: 10.1016/j.beem.2012.01.004. Epub 2012 May 31.
Congenital hypoparathyroidism encephalopathy in a 34-year-old man.
Wang XJ, Qiu X.
Asian J Surg. 2023 Nov;46(11):4787-4788. doi: 10.1016/j.asjsur.2023.05.093. Epub 2023 Jun 2.
Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.
Roszko KL, Stapleton Smith LM, Sridhar AV, Roberts MS, Hartley IR, Gafni RI, Collins MT, Fox JC, Nemeth EF.
J Bone Miner Res. 2022 Oct;37(10):1926-1935. doi: 10.1002/jbmr.4659. Epub 2022 Aug 22.
The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases.
Hannan FM, Kallay E, Chang W, Brandi ML, Thakker RV.
Nat Rev Endocrinol. 2018 Dec;15(1):33-51. doi: 10.1038/s41574-018-0115-0.
Congenital neuroblastoma in a neonate with hypoparathyroidism-retardation-dysmorphism syndrome.
Golan-Tripto I, Ling E, Hershkovitz E, Fruchtman Y, Hazan G.
Clin Dysmorphol. 2020 Jan;29(1):46-48. doi: 10.1097/MCD.0000000000000286.
Hypoparathyroidism.
[No authors listed]
West J Med. 1979 Oct;131(4):298-304.
